MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
Industry: Massachusetts
Mersana Therapeutics, Inc. (NASDAQ: MRSN)*
*Key People: Mersana
Parents
Mersana Therapeutics, Inc. (NASDAQ: MRSN)*
Children
2023: Mersana Therapeutics will lay off around half of its workforce after the Phase III failure of its lead antibody-drug conjugate (ADC), upifitamab rilsodotin (UpRi), in ovarian cancer
Anna Protopapas, Mersana Therapeutics, Inc. - President, CEO & Director (2021)
Arvin Yang, Mersana Therapeutics, Inc. - Senior VP & Chief Medical Officer (2021)
Julie Olson, Ph.D., President and CEO of Mersana
Marty Huber, CEO, Mersana (2025)
Number of employees: 228 (2022)
Jumps
Finance & Acquisitions: Mersana
Organization & Developments: Mersana